ENTITY
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

57
Analysis
Health Care • Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
bullish•SanBio Co Ltd
•16 Jun 2026 10:00•Issuer-paid

SanBio Co Ltd (4592 JP): Q1 FY01/27 flash update

In Q1 FY01/27, the company reported no operating revenue, with an operating loss of JPY953mn and a net loss of JPY836mn. Non-operating income...

Logo
118 Views
Share
bullish•SanBio Co Ltd
•18 Mar 2026 11:00•Issuer-paid

SanBio Co Ltd (4592 JP): Full-year FY01/26 flash update

In FY01/26, SanBio reported no operating revenue, an operating loss of JPY3.8bn, and R&D expenses of JPY2.7bn. The company anticipates...

Logo
197 Views
Share
bullish•SanBio Co Ltd
•15 Dec 2025 17:00•Issuer-paid

SanBio Co Ltd (4592 JP): Q3 FY01/26 flash update

In cumulative Q3 FY01/26, the company reported no operating revenue and an operating loss of JPY2.7bn. The company forecasts a recurring loss of...

Logo
337 Views
Share
bullish•SanBio Co Ltd
•13 Sep 2025 09:00•Issuer-paid

SanBio Co Ltd (4592 JP): 1H FY01/26 flash update

In 1H FY01/26, the company reported no operating revenue, with an operating loss of JPY1.9bn and R&D expenses increasing by 31.5%...

Logo
462 Views
Share
bullish•SanBio Co Ltd
•18 Mar 2025 11:00•Issuer-paid

SanBio Co Ltd (4592 JP): Full-year FY01/25 flash update

SanBio reported no operating revenue for FY01/25, with an operating loss of JPY3.5bn, narrowing from JPY4.5bn. Non-operating income was JPY628mn,...

Logo
270 Views
Share
x